RFP - supply of diabetes agents: SGLT-2 inhibitors, GLP-1 agonists and DPP-4 inhibitors – ADDENDUM ADDED TO EXTEND SOLE SUPPLY PERIOD
15 January 2020
PHARMAC invites proposals for the supply of diabetes agents: SGLT-2 inhibitors, GLP-1 agonists and DPP-4 inhibitors in New Zealand.
This request for proposals (RFP) document incorporates the following schedules:
- Schedule 1 specifies the pharmaceutical for which PHARMAC is requesting proposals and sets out the background to the RFP and the types of proposals sought;
- Schedule 2 describes the process that PHARMAC expects to follow in relation to the RFP;
- Schedule 3 sets out information about the estimated size of the current subsidised market for the pharmaceutical; and
- Schedule 4 contains the RFP form in which you are to provide details of your proposals. [DOCX, 46 KB]
For important information regarding a change in RFP requirements please read the addendum, '2020-02-13 ADDENDUM - EXTENSION TO SOLE SUPPLY PERIOD' above.
If you wish to submit a proposal, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz(external link)) no later than 4pm NZT Monday 16 March 2020 - RFx ID 22162611.
PHARMAC will be holding a supplier briefing and Q&A on Monday 3 February 2020 in Auckland to provide information about the types of proposals sought through this RFP. Full details to be confirmed and will be published on GETS. Please contact email@example.com if you would like to attend.
We encourage suppliers to register with GETS and subscribe to this RFP. If you have any questions about this RFP, please post these on GETS (www.gets.govt.nz(external link)).
We look forward to receiving your proposals.
Last updated: 13 February 2020